Neostigmine and Atropine for the Treatment of Headache After Dural Puncture Placement
Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate Neostigmine and Atropine to treat post-dural
puncture headache (PDPH) to reduce the proportion of postpartum women with a PDPH requiring
epidural blood patch (EBP) who developed a PDPH after accidental dural puncture.